Bioactive Hydrogel Encapsulated Dual-Gene Engineered Nucleus Pulposus Stem Cells Towards Intervertebral Disc Tissue Repair

Yuchen Ye,Panpan Xu,Cai Li,Shichang Jin,Jie Hu,Yuekun Fang,Kun Zhu,Gang Xu,Zhongbing Han,Zhili Zhang,Nan Wu,Pan Jiang,Zhengqi Bao,Pinghui Zhou,Changchun Zhang
DOI: https://doi.org/10.1016/j.cej.2022.139717
2022-01-01
SSRN Electronic Journal
Abstract:Intervertebral disc (IVD) degeneration is a pathological process that affects the molecular, cellular , tissue levels, but neither conservative nor surgical treatments currently address its root causes. Recent developments in genetic engineering , tissue engineering technologies indicate that a biomedical treatment for IVD degener-ation may be possible. Lentivirus has been utilized in this study as a gene vector to introduce insulin-like growth factor-1 (IGF-1) and transforming growth factor-beta 3 (TGF-beta 3) into nucleus pulposus mesenchymal stem cells (NPMSCs) for the first time. This resulted in the construction of dual-gene engineered seed cells that could differentiate into nucleus pulposus cells overexpressing both IGF-1 and TGF-beta 3 growth factors. A bicomponent polymer network (BCN) hydrogel based on gelatin methacrylate (GelMA) and hyaluronic acid methacrylate (HAMA) was prepared and used as a carrier to deliver genetically engineered NPMSCs to the target tissues. BCN hydrogels effectively upregulated the extracellular matrix expression and nucleus pulposus differentiation after being loaded with NPMSCs overexpressing IGF-1 and TGF-beta 3. The novel biotherapeutic modality presented could be used to repair degenerated IVD tissues, replenish seed cells with a rich potential, and promote extracellular matrix synthesis and nucleus pulposus differentiation, thereby providing a theoretical basis and experimental rationale for the etiological treatment of IVD degeneration.
What problem does this paper attempt to address?